Taiwan FDA registration b8b5fdb1c8de8fdd436c738d4a64a145

Insulin pen type syringe Novo Pen 4

TW: 胰島素筆型注射器諾和筆4

Taiwan·Risk Class 2·NOVO NORDISK A/S;; NOVO NORDISK (CHINA) PHARMACEUTICALS CO., LTD.·Registered May 14, 2010 – May 14, 2025Expired

Registration details

Analysis ID: b8b5fdb1c8de8fdd436c738d4a64a145
Customs Code: DHA04200026309

Company information

Manufacturer: NOVO NORDISK A/S;; NOVO NORDISK (CHINA) PHARMACEUTICALS CO., LTD.
Manufacturer Country: China;;Denmark
Authorized Representative: NOVO NORDISK PHARMA (TAIWAN) LTD.

Product details

Intended Use: For details, it is Chinese approved copy of the imitation order
Product Type (Level 1): J General hospital and personal use equipment
Product Type (Level 2): J.5860 活塞式注射筒;; J.6920 注射針導引器
Import Information: Chinese goods;; input

Dates and status

Registration Date: May 14, 2010
Expiry Date: May 14, 2025

About this record

Access comprehensive regulatory information for Insulin pen type syringe Novo Pen 4 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b8b5fdb1c8de8fdd436c738d4a64a145 and manufactured by NOVO NORDISK A/S;; NOVO NORDISK (CHINA) PHARMACEUTICALS CO., LTD.. The authorized representative in Taiwan is NOVO NORDISK PHARMA (TAIWAN) LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.